Scholar Rock Holding (SRRK) Other Non-Current Assets (2017 - 2026)

Scholar Rock Holding (SRRK) recorded quarterly Other Non-Current Assets of $3.8 million in Q1 2026, up 530.3% quarter-over-quarter from $604000.0 in Q4 2025, and up 58.16% on a YoY basis from $2.4 million in Q1 2025.

Scholar Rock Holding (SRRK) Other Non-Current Assets (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Other Non-Current Assets history runs 10 years deep, the most recent figure standing at $3.8 million for Q1 2026.

  • In Q1 2026, Other Non-Current Assets rose 58.16% year-over-year to $3.8 million; the TTM figure through Mar 2026 stood at $3.8 million (up 58.16% YoY), while the FY2025 annual figure was $604000.0, down 74.91% from the prior year.
  • Other Non-Current Assets was $3.8 million for Q1 2026 at Scholar Rock Holding, up from $604000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $3.8 million in Q3 2025 to a low of $604000.0 in Q4 2025.
  • Historically, Other Non-Current Assets has averaged $2.5 million across 5 years, with a median of $2.5 million in 2022.
  • The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets soared 150.8% in 2022, then slumped 74.91% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $2.5 million in 2022, then decreased by 3.64% to $2.4 million in 2023, then changed by 0.0% to $2.4 million in 2024, then plunged by 74.91% to $604000.0 in 2025, then surged by 530.3% to $3.8 million in 2026.
  • The last three Other Non-Current Assets figures came in at $3.8 million (Q1 2026), $604000.0 (Q4 2025), and $3.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 12.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 60,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.26 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Scholar Rock Holding 6.03 Bn 5.55 Bn - 3.81 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.81 Mn
Dec 31, 2025 604,000.00
Sep 30, 2025 3.81 Mn
Jun 30, 2025 2.96 Mn
Mar 31, 2025 2.41 Mn
Dec 31, 2024 2.41 Mn
Sep 30, 2024 2.41 Mn
Jun 30, 2024 2.41 Mn
Mar 31, 2024 2.41 Mn
Dec 31, 2023 2.41 Mn
Sep 30, 2023 2.61 Mn
Jun 30, 2023 2.61 Mn
Mar 31, 2023 2.50 Mn
Dec 31, 2022 2.50 Mn
Sep 30, 2022 2.50 Mn
Jun 30, 2022 2.50 Mn
Mar 31, 2022 2.50 Mn
Dec 31, 2021 2.50 Mn
Sep 30, 2021 2.50 Mn
Jun 30, 2021 2.50 Mn